Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger CW-type and PWWP domain-containing protein 2 (ZCWPW2) is a nuclear protein expressed in humans that functions as a "histone methylation reader," specifically recognizing lysine 4 methylation states (H3K4me0, H3K4me1, H3K4me2, H3K4me3) on histone H3[6][9]. It contains highly conserved CW-type zinc finger and PWWP domains, structural motifs that allow it to bind specific histone modifications and contribute to chromatin structure regulation[4]. ZCWPW2 is tightly co-evolved with the methyltransferase PRDM9 and is hypothesized to localize to sites of PRDM9 binding; this suggests it may participate in meiotic recombination, possibly by recruiting or positioning recombination machinery during double-strand break (DSB) formation or repair[2]. The detailed molecular function of ZCWPW2 remains uncertain, but, like related zinc finger proteins, it is likely involved in transcriptional regulation, chromatin remodeling, and maintaining genome integrity. There are no established drugs targeting ZCWPW2, nor is it considered a classical therapeutic target, and no direct disease associations have been defined[2][6][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger CW-type and PWWP domain-containing protein 2 (ZCWPW2).